Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration

Liver Transplantation

Volumn 16, Issue 10, 2010, Pages 1195-1206

  Lam, Shuk Pik ^a   Luk, John M ^a   Man, Kwan ^a   Ng, Kevin T P ^a   Cheung, Cindy K ^a   Stefan, Rose John ^b   Lo, Chung Mau ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BETA CATENIN; BILIRUBIN; BIOLOGICAL MARKER; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD34 ANTIGEN; CYTOKERATIN 18; CYTOKERATIN 19; GALACTOSAMINE; GLYCOPROTEIN GP 130; HEPATOCYTE NUCLEAR FACTOR 3BETA; HYBRID PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN OV6; STAT3 PROTEIN; UNCLASSIFIED DRUG; WNT5A PROTEIN; GREEN FLUORESCENT PROTEIN; IL6ST PROTEIN, RAT; MITOGEN ACTIVATED PROTEIN KINASE; STAT3 PROTEIN, RAT;

ACUTE LIVER INJURY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; IMMUNOFLUORESCENCE TEST; LIVER CELL; LIVER CELL CULTURE; LIVER INJURY; LIVER REGENERATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WOUND HEALING; ANIMAL; BIOSYNTHESIS; BLOOD; CELL CULTURE; CHEMOTAXIS; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; SPRAGUE DAWLEY RAT; TIME; TOXIC HEPATITIS; TRANSGENIC RAT; TRANSPLANTATION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; COCULTURE TECHNIQUES; CYTOKINE RECEPTOR GP130; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; FEMALE; GALACTOSAMINE; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HEPATOCYTES; INTERLEUKIN-6; LIVER REGENERATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; PARACRINE COMMUNICATION; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS;

EID: 79952118341     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22136     Document Type: Article

References (40)

1. Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005;106:419-427.
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284: 143-147.
3. Snykers S, De Kock J, Rogiers V, Vanhaecke T. In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells 2009;27:577-605.
4. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002;109:1291-1302.
5. Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, Chou SH, et al. In vitro hepatic differentiation of human mesenchymal stem cells. HEPATOLOGY 2004;40:1275-1284.
6. Lange C, Bassler P, Lioznov MV, Bruns H, Kluth D, Zander AR, et al. Hepatocytic gene expression in cultured rat mesenchymal stem cells. Transplant Proc 2005;37: 276-279.
7. Aurich I, Mueller LP, Aurich H, Luetzkendorf J, Tisljar K, Dollinger MM, et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 2007;56:405-415.
8. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer 2008;8: 387-398.
9. Nemeth MJ, Mak KK, Yang Y, Bodine DM. beta-Catenin expression in the bone marrow microenvironment is required for long-term maintenance of primitive hematopoietic cells. Stem Cells 2009;27:1109-1119.
10. Ke Z, Zhou F, Wang L, Chen S, Liu F, Fan X, et al. Down-regulation of Wnt signaling could promote bone marrow-derived mesenchymal stem cells to differentiate into hepatocytes. Biochem Biophys Res Commun 2008; 367:342-348.
11. Yoshida Y, Shimomura T, Sakabe T, Ishii K, Gonda K, Matsuoka S, et al. A role of Wnt/beta-catenin signals in hepatic fate specification of human umbilical cord bloodderived mesenchymal stem cells. Am J Physiol Gastrointest Liver Physiol 2007;293:G1089-G1098.
12. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 2003;162:899-908.
13. Fujio Y, Matsuda T, Oshima Y, Maeda M, Mohri T, Ito T, et al. Signals through gp130 upregulate Wnt5a and contribute to cell adhesion in cardiac myocytes. FEBS Lett 2004;573:202-206.
14. Rose-John S, Heinrich PC. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 1994;300:281-290.
15. Rose-John S, Scheller J, Elson G, Jones SA. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 2006;80:227-236.
16. Migita K, Abiru S, Maeda Y, Daikoku M, Ohata K, Nakamura M, et al. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Hum Immunol 2006;67:27-32.
17. Fischer M, Goldschmitt J, Peschel C, Kallen KJ, Brakenhoff JPJ, Wollmer A, et al. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol 1997;15:142-145.
18. Hecht N, Pappo O, Shouval D, Rose-John S, Galun E, Axelrod JH. Hyper-IL-6 gene therapy reverses fulminant hepatic failure. Mol Ther 2001;3:683-687.
19. Peters M, Blinn G, Solem F, Fischer M, Meyer zum Büschenfelde KH, Rose-John S. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6. J Immunol 1998;161:3575-3581.
20. Erices A, Conget P, Rojas C, Minguell JJ. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Exp Cell Res 2002;280:24-32.
21. Hatano E, Tanaka A, Kanazawa A, Tsuyuki S, Tsunekawa S, Iwata S, et al. Inhibition of tumor necrosis factor-induced apoptosis in transgenic mouse liver expressing creatine kinase. Liver Int 2004;24:384-393.
22. Wang PP, Wang JH, Yan ZP, Hu MY, Lau GK, Fan ST, et al. Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction. Biochem Biophys Res Commun 2004;320:712-716.
23. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
24. Schroers A, Hecht O, Kallen KJ, Pachta M, Rose-John S, Grötzinger J. Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane. Protein Sci 2005;14:783-790.
25. Ishikawa F, Drake CJ, Yang S, Fleming P, Minamiguchi H, Visconti RP, et al. Transplanted human cord blood cells give rise to hepatocytes in engrafted mice. Ann N Y Acad Sci 2003;996:174-185.
26. Wang X, Ge S, McNamara G, Hao QL, Crooks GM, Nolta JA. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood 2003;101:4201-4208.
27. Luk JM, Wang PP, Lee CK, Wang JH, Fan ST. Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods 2005;305:39-47.
28. Kang XQ, Zang WJ, Bao LJ, Li DL, Xu XL, Yu XJ. Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro. Cell Biol Int 2006;30:569-575.
29. Miyazaki M, Akiyama I, Sakaguchi M, Nakashima E, Okada M, Kataoka K, et al. Improved conditions to induce hepatocytes from rat bone marrow cells in culture. Biochem Biophys Res Commun 2002;298:24-30.
30. Xu J, Liu X, Jiang Y, Chu L, Hao H, Liua Z, et al. MAPK/ ERK signaling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell. J Cell Mol Med 2008;12:2395-2406.
31. Angenieux B, Schorderet DF, Arsenijevic Y. Epidermal growth factor is a neuronal differentiation factor for retinal stem cells in vitro. Stem Cells 2006;24:696-706.
32. Hardt SE, Sadoshima J. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res 2002;90:1055-1063.
33. Holmes T, O'Brien TA, Knight R, Lindeman R, Symonds G, Dolnikov A. The role of glycogen synthase kinase-3beta in normal haematopoiesis, angiogenesis and leukaemia. Curr Med Chem 2008;15:1493-1499.
34. Kremenevskaja N, von Wasielewski R, Rao AS, Schöfl C, Andersson T, Brabant G. Wnt-5a has tumor suppressor activity in thyroid carcinoma.Oncogene 2005;24:2144-2154.
35. Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, et al. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 2010;29:2036-2046.
36. Chen T, Wang LH, Farrar WL. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res 2000;60:2132-2135.
37. Yang L, Wang L, Lin HK, Kan PY, Xie S, Tsai MY, et al. Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells. Biochem Biophys Res Commun 2003;305:462-469.
38. Valerio A, Ferrario M, Dreano M, Garotta G, Spano P, Pizzi M. Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. Mol Cell Neurosci 2002;21:602-615.
39. Walter MN, Wright KT, Fuller HR, MacNeil S, Johnson WE. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Exp Cell Res 2010;316: 1271-1281.
40. Walker PA, Harting MT, Jimenez F, Shah SK, Pati S, Dash PK, et al. Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an NfkappaB mediated increase in interleukin-6 production. Stem Cells Dev 2010;19:867-876.